Pure Global
NCT06103253

Effect of Probiotic on the Gut Microbiota of Healthy Volunteers

Effect of Intervention With Probiotic on the Gut Microbiota of Healthy Volunteers: a Placebo-controlled Randomized Trial
Wecare Probiotics Co., Ltd.·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Adults
Drug/Device/Intervention
a Bla80 group
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Wecare Probiotics Co., Ltd.
Location
Zhengzhou, China
Timeline & enrollment
Phase
N/A
Start date
Apr 20, 2023
End date
Jun 28, 2023
Enrollment
112 participants
Primary outcome

gut microbiota diversity

Summary

The goal of this placebo-controlled randomized trial is to test the effect of intervention
 with Bifidobacterium animalis subsp. lactis BLa80 on the composition of the gut microbiota of
 healthy volunteers. The main question it aims to answer is whether probiotic can effectively
 regulate intestinal flora. Participants will take a package of probiotics every day, and
 their weight was recorded once a week using a weight scale. Blood and stool tests were
 conducted before and after taking probiotics.

ICD-10 classifications
ObesityHealthy person accompanying sick personObesity, unspecifiedRoutine general health check-up of inhabitants of institutionsLifestyle-related condition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06103253
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06103253 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Completed. The study focuses on Healthy Adults. Target enrollment is 112 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.